Bioptik Technology, Inc. engages in the research and development, manufacture, and sale of hyaluronic acid and skincare product. Its products include monitoring systems for blood glucose, uric acid and cholesterol. The company was founded on June 1, 1999 and is headquartered in Miaoli, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company